Paras Healthcare IPO Details: Price, Dates & Financials
The Paras Healthcare IPO is a closed mainboard Bookbuilding offer (Fresh capital cum OFS) that opened on 21 October 2026. The Paras Healthcare IPO closed on 23 October 2026, with an issue price of ₹693 per share. The Paras Healthcare IPO has a face value of ₹1 and a lot size of 21 shares. The Paras Healthcare IPO size aggregates up to ₹1,450 crore, listing on NSE & BSE on 28 October 2026. The Paras Healthcare IPO allotment is expected on 26 October 2026.
On the financial front, the Paras Healthcare IPO reported revenue of ₹479 crore for 30 Jun 2026, compared with ₹1,629 crore for 31 Mar 2026. The Paras Healthcare IPO PAT was ₹50 crore against ₹44 crore. The Paras Healthcare IPO EBITDA stood at ₹113 crore with a 23.70% margin. The Paras Healthcare IPO net worth as of 30 Jun 2026 was ₹445 crore.
Always verify The Paras Healthcare IPO details and GMP data with the official offer document before investing in the Paras Healthcare IPO.
Financial Summary
Amount in ₹ Crore
Metric
30 Jun 2026
31 Mar 2026
31 Mar 2025
Total Assets
2,203
2,071
1,810
Revenue
479
1,629
1,314
PAT
50
44
-58
EBITDA
113
336
156
Net Worth
445
395
280
Reserves
435
385
271
Total Borrowing
1,429
1,394
1,232
Paras Healthcare IPO Financials FAQs
Revenue of Paras Healthcare (Amount in ₹ Crore) — 30 Jun 2026: 479; 31 Mar 2026: 1,629; 31 Mar 2025: 1,314. Profit after tax (PAT) — 30 Jun 2026: 50; 31 Mar 2026: 44; 31 Mar 2025: -58.
EBITDA of Paras Healthcare (Amount in ₹ Crore) — 30 Jun 2026: 113; 31 Mar 2026: 336; 31 Mar 2025: 156. The EBITDA margin is 23.70%.
Total assets — 30 Jun 2026: 2,203; 31 Mar 2026: 2,071; 31 Mar 2025: 1,810. Net worth — 30 Jun 2026: 445; 31 Mar 2026: 395; 31 Mar 2025: 280. Reserves & surplus — 30 Jun 2026: 435; 31 Mar 2026: 385; 31 Mar 2025: 271. (Amount in ₹ Crore)
Total borrowing of Paras Healthcare (Amount in ₹ Crore) — 30 Jun 2026: 1,429; 31 Mar 2026: 1,394; 31 Mar 2025: 1,232. Debt-to-equity ratio: 3.21.
The financials shown for Paras Healthcare IPO are taken from the company's offer document (DRHP/RHP/prospectus) filed with the exchange and SEBI, and are updated here when restated figures are published. Always cross-check with the official offer document before investing.
Look at the trend of revenue and PAT across periods, whether EBITDA is growing along with revenue, and whether net worth is rising while borrowings stay under control. The first column may be a part-year (interim) period, so compare full financial years with each other.
GMP and IPO data are unofficial and for information only — not investment advice.
Read the full disclaimer.
